Bill Sponsor
Senate Bill 3420
115th Congress(2017-2018)
Accountability in Opioid Advertising Act
Introduced
Introduced
Introduced in Senate on Sep 6, 2018
Overview
Text
Introduced
Sep 6, 2018
Latest Action
Sep 6, 2018
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
3420
Congress
115
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Democrat
California
Republican
Colorado
Senate Votes (0)
House Votes (0)
No Senate votes have been held for this bill.
Summary

Accountability in Opioid Advertising Act

This bill requires the Food and Drug Administration to prioritize the review of advertising and other promotional materials for drug for serious, life-threatening diseases or conditions or substance use disorders, especially opioids (drugs with effects similar to opium, such as certain pain medications)and drugs used in the treatment of opioid use disorders.

Text (1)
September 6, 2018
Actions (2)
09/06/2018
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
09/06/2018
Introduced in Senate
Public Record
Record Updated
Jan 11, 2023 1:41:22 PM